UniProtKB/Swiss-Prot P15289: Variant p.Asp335Val

• Variant information
• Sequence information
• Literature citations
• All

Variant information

Variant position: 335 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: LP/P [Disclaimer: Variants classification is intended for research purposes only, not for clinical and diagnostic use. The label disease variant is assigned according to literature reports on probable disease-association that can be based on theoretical reasons. This label must not be considered as a definitive proof for the pathogenic role of a variant.] The variants are classified into three categories: LP/P, LB/B and US.

• LP/P: likely pathogenic or pathogenic.
• LB/B: likely benign or benign.
• US: uncertain significance

Residue change: From Aspartate (D) to Valine (V) at position 335 (D335V, p.Asp335Val). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: Change from medium size and acidic (D) to medium size and hydrophobic (V) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: -3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

• Lowest score: -4 (low probability of substitution).
• Highest score: 11 (high probability of substitution).

More information can be found on the following page
Variant description: In MLD; late-infantile-onset; loss of enzymatic activity. Any additional useful information about the variant.
Other resources: Links to websites of interest for the variant.

• Variant rs74315475 [ dbSNP | Ensembl ]

Sequence information

Variant position: 335 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 507 The length of the canonical sequence.
Location on the sequence: LAFWPGHIAPGVTHELASSL D LLPTLAALAGAPLPNVTLDG The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

• Type: the type of sequence feature.
• Positions: endpoints of the sequence feature.
• Description: contains additional information about the feature.

Type	Positions	Description
Chain	19 – 507	Arylsulfatase A
Chain	19 – 444	Arylsulfatase A component B
Glycosylation	350 – 350	N-linked (GlcNAc...) asparagine
Disulfide bond	300 – 414
Helix	333 – 335

Literature citations

Identification of seven novel mutations associated with metachromatic leukodystrophy.
Barth M.L.; Fensom A.; Harris A.;
Hum. Mutat. 6:170-176(1995)
Cited for: VARIANTS MLD LEU-82; TYR-172; CYS-201; GLN-311; VAL-335 AND TRP-390; Characterization of two arylsulfatase A missense mutations D335V and T274M causing late infantile metachromatic leukodystrophy.
Hess B.; Kafert S.; Heinisch U.; Wenger D.A.; Zlotogora J.; Gieselmann V.;
Hum. Mutat. 7:311-317(1996)
Cited for: CHARACTERIZATION OF VARIANTS MET-274 AND VAL-335; Metachromatic leukodystrophy: subtype genotype/phenotype correlations and identification of novel missense mutations (P148L and P191T) causing the juvenile-onset disease.
Qu Y.; Shapira E.; Desnick R.J.;
Mol. Genet. Metab. 67:206-212(1999)
Cited for: VARIANTS MLD LEU-148; THR-191; VAL-335; TYR-397 AND LEU-426; Identification of nine novel arylsulfatase A (ARSA) gene mutations in patients with metachromatic leukodystrophy (MLD).
Eng B.; Nakamura L.N.; O'Reilly N.; Schokman N.; Nowaczyk M.M.J.; Krivit W.; Waye J.S.;
Hum. Mutat. 22:418-419(2003)
Cited for: VARIANTS MLD LEU-155; GLN-181; VAL-212; HIS-306; SER-325; VAL-335; LEU-426 AND SER-429; Molecular bases of metachromatic leukodystrophy in Polish patients.
Lugowska A.; Ploski R.; Wlodarski P.; Tylki-Szymanska A.;
J. Hum. Genet. 55:394-396(2010)
Cited for: VARIANTS MLD SER-179; SER-247; CYS-288; VAL-335; LYS-382; GLN-390; TRP-390; TYR-397 AND LEU-426;